Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
BDRX holding history
Biodexa Pharmaceuticals Plc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BDRX overviewAll 13F holders of BDRXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −700−100.0% | Sold out | Holders |
| Q1 2025 | 700 | $924 | <0.1% | +700 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −14,320−100.0% | Sold out | Holders |
| Q3 2024 | 14,320 | $4.04K | <0.1% | +14,304+89,400.0% | Added | Holders |
| Q2 2024 | 16 | $14 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 16 | $26 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 16 | $43 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 16 | $80 | <0.1% | −1,352−98.8% | Reduced | Holders |
| Q2 2023 | 1,368 | $94 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,368 | $534 | <0.1% | +1,368 | New | Holders |